This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Fixed drug eruption

Authoring team

  • a drug eruption that occurs at the same site(s) each time the offending drug is taken (1)
    • causes include:
      • phenolphthalein (present in many over the counter laxatives)
      • barbiturates
      • NSAIDs
      • codeine
      • paracetamol
      • tetracyclines
      • chlordiazepoxide
      • sulphonamides (includes sulphonamide antibiotics, sulphonylureas, thiazide diuretics)
    • lesions:
      • usually appear within a couple of days to weeks after drug ingestion and resolves with the withdrawal of the offending drug
      • often painful, pruritic or burning
      • appear as clearly demarcated oval or round erythematous plaques
      • become violaceous after 1-2 days
      • typically 1-3 lesions
      • common sites - hands, feet, glans penis, lips, sacral skin
      • lesions fade after about 1 week and leave a hyperpigmented patch that may last for several months
      • rare presentations include periorbital or generalized hypermelanosis (1)

Drug rechallenge can be used to find out the causative drug. Patch testing and intradermal skin testing can also be used in some patients (1)

Management options include

  • identifying and discontinuing the offending drug
  • systemic antihistamines with topical corticosteroids for the lesions
  • systemic corticosteroids – for extensive lesions with bullae (1)

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.